靶点-  | 
 | 
 | 
 | 
 | 
 | 
最高研发阶段临床3期  | 
首次获批国家/地区-  | 
首次获批日期-  | 
An Open Label Phase 2 Study to Evaluate the Effects of a Local Anesthetic, Anti-inflammatory Medications and Compression Garments on RZL-012-Induced Adverse Events
This is a Phase 2, open-label, 2-stage, adaptive-design study in which subjects will be randomized into one of 5 treatment groups comprised of RZL-012 with or without additional study treatments:
100 项与 Raziel Health LLC 相关的临床结果
0  项与 Raziel Health LLC 相关的专利(医药)
100 项与 Raziel Health LLC 相关的药物交易
100 项与 Raziel Health LLC 相关的转化医学